“What a long, strange trip it’s been.”
When we launched Budding Trends years ago as a modest little blog focused on cannabis law, the idea that we’d one day spend serious time tracking potential widespread access to psychedelics was, to put it mildly, not part of the original pitch deck. And yet, here we are.
This is the last of 13 posts describing the impacts of marijuana’s rescheduling. An homage to Phish’s historic run at Madison Square Garden in the Summer of 2017, Budding Trends Baker’s Dozen has addressed how rescheduling affects various areas of the law and our daily lives. We hope you’ve enjoyed the run.
The story of
This is the twelfth of 13 posts describing the impacts of marijuana’s rescheduling. An homage to Phish’s historic run at Madison Square Garden in the Summer of 2017, Budding Trends Baker’s Dozen will address how rescheduling affects various areas of the law and our daily lives. Enjoy the run.
The rollercoaster ride that is the
This is the seventh of 13 posts describing the impacts of marijuana’s rescheduling. An homage to Phish’s historic run at Madison Square Garden in the Summer of 2017, Budding Trends Baker’s Dozen will address how rescheduling affects various areas of the law and our daily lives. Enjoy the run.
Those of you who have been
The Trump administration’s interest in psychedelics as medicine has continued to come into focus over the past several weeks, with two developments suggesting that momentum at the federal level continues to grow. Both President Trump and Secretary of Health and Human Services Robert F. Kennedy Jr. continue to take actions signaling their support for the
Here at Budding Trends, we like to roll up our “Top 10 Weed Roundup” between the sacred and renowned 420 holidays. Each year, we pack a recap post with 10 highly read blog posts since the previous 420 to see what’s shakin’ on shakedown street over the last year — and we have seen
What’s old is new again. The beginning of the year has brought us a sense of renewal, and taking a cue from Congress, we are revisiting some issues in a new light. Congress recently dusted off a bill that failed to pass in its previous forms for various reasons, including concerns about the bill’s constitutionality.
It’s that time of year again. Our annual round-up featuring some of the most read content on Budding Trends in the past year. This year’s edition has a little something for everyone: marijuana, hemp, mushrooms, state law, federal law, banking, intellectual property, and more!
Before we dive right in, we want to plug our January
I suspect my entry into the hemp market was similar to many of yours. I have never been a regular consumer of THC and consider myself a rule follower. A few years ago, I noticed new cannabis boutiques popping up in my neighborhood. Then canned hemp drinks started to appear at grocery stores around town.
On August 11, 2025, the U.S. Drug Enforcement Administration officially transmitted a request to the Department of Health and Human Services to loosen the federal restriction on psilocybin, seeking to move one of the better-known psychedelics from Schedule I to Schedule II under the Controlled Substances Act. The petition was submitted by a familiar